Pfizer ends research for Alzheimer's, Parkinson's drugs

The drug company - which makes the lucrative drug, Viagra - said it was ending its neuroscience research to focus on areas where it was strongest.

by

    Alzheimer's and Parkinson's sufferers have been dealt a blow, with drug maker Pfizer deciding to end its research into the debilitating diseases.

    Many sufferers and their families had felt new hope when the pharmaceutical giant began early-stage research, but the company has now decided to invest elsewhere.

    Al Jazeera's John Hendren reports.


    YOU MIGHT ALSO LIKE

    'We scoured for days without sleeping, just clothes on our backs'

    'We scoured for days without sleeping, just clothes on our backs'

    The Philippines’ Typhoon Haiyan was the strongest storm ever to make landfall. Five years on, we revisit this story.

    How Moscow lost Riyadh in 1938

    How Moscow lost Riyadh in 1938

    Russian-Saudi relations could be very different today, if Stalin hadn't killed the Soviet ambassador to Saudi Arabia.

    Daughters of al-Shabab

    Daughters of al-Shabab

    What draws Kenyan women to join al-Shabab and what challenges are they facing when they return to their communities?